×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Successful Patient Input to Regulatory and Health Technology Assessment Processes Along the Development Path: Examples of How to Optimize Impact
Session Chair(s)
Eleanor M. Perfetto, PhD, MS
Independent Consultant
Consultant, United States
To guide patient focused drug development, patient input is sought by regulators and Health Technology Assessment (HTAs) in different ways around the world. The session will explore options to increase impact on development through greater coordination and information sharing.
Learning Objective : Understand different options and processes for patient input into regulatory and HTA advice across key product development milestones. Explore best practices in maximising the overall impact of patient input on development plans. Identify policy and process changes that would allow continuous improvement and learning across the various set pieces for patient engagement.
Speaker(s)
Panelist
Magdalena Harrington, PhD
Pfizer, United States
Senior Director, Patient-Centered Outcomes Assessment (PCOA) Team Lead
Panelist
Anna Hyde, MA
Arthritis Foundation, United States
Vice President of Advocacy & Access
Have an account?